Table 6 Summary of predicted resource use
Costs | MIDO | SOC | Difference |
|---|---|---|---|
Drug costs | |||
Induction and initiation | £8242 | £1747 | £6495 |
Consolidation | £13,790 | £2602 | £11,188 |
Monotherapy | £36,021 | £0 | £36,021 |
Secondary therapy costs | £1354 | £1531 | − £177 |
Adverse events costs | |||
AEs induction costs | £5293 | £5557 | − £264 |
AEs consolidation costs | £5198 | £4659 | £539 |
AEs monotherapy costs | £171 | £0 | £171 |
Routine care costs | |||
Routine care costs during drug treatment | £9586 | £8045 | £1541 |
Routine care after drug treatment | £122,768 | £132,429 | − £9661 |
SCT cost | £55,245 | £46,172 | £9073 |
Mortality costs | £9656 | £10,511 | − £855 |
Total | £267,325 | £213,253 | £54,072 |